Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment

被引：0
|
作者：
Alexandros A. Drosos
Eleftherios Pelechas
Evripidis Kaltsonoudis
Paraskevi V. Voulgari
机构：
[1] University of Ioannina,Rheumatology Clinic, Department of Internal Medicine, Medical School
来源：
Current Rheumatology Reports | 2020年 / 22卷
关键词：
csDMARDs; bDMARDs; Triple therapy; Cost-effectiveness; Work productivity; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators
    Jansen, Jeroen P.
    Incerti, Devin
    Mutebi, Alex
    Peneva, Desi
    MacEwan, Joanna P.
    Stolshek, Bradley
    Kaur, Primal
    Gharaibeh, Mahdi
    Strand, Vibeke
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 703 - 714
  • [32] COST-EFFECTIVENESS ANALYSIS OF THE TREATMENT OF RHEUMATOID-ARTHRITIS - FEASIBILITY STUDY
    PETTINGILL, BF
    CLINICAL RESEARCH, 1980, 28 (01): : A149 - A149
  • [33] Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States
    Claxton, Lindsay
    Taylor, Matthew
    Gerber, Robert A.
    Gruben, David
    Moynagh, Dermot
    Singh, Amitabh
    Wallenstein, Gene, V
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (11) : 1991 - 2000
  • [34] A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis
    Choi, HK
    Seeger, JD
    Kuntz, KM
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (06) : 1156 - 1165
  • [35] New therapeutic options for the treatment of rheumatoid arthritis
    Lorenz, HM
    Kalden, JR
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2001, 60 (05): : 326 - 332
  • [36] Current Therapeutic Options in the Treatment of Rheumatoid Arthritis
    Koehler, Birgit M.
    Guenther, Janine
    Kaudewitz, Dorothee
    Lorenz, Hanns-Martin
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07)
  • [37] The cost-effectiveness of therapeutic options for essential thrombocythemia.
    Golub, RM
    Dave, S
    Adams, JR
    Bennett, CL
    BLOOD, 2001, 98 (11) : 426A - 426A
  • [38] COST-EFFECTIVENESS ANALYSIS OF TWO RITUXIMAB BASED THERAPEUTIC REGIMENS FOR LONGSTANDING RHEUMATOID ARTHRITIS
    Quartuccio, L.
    Di Bidino, R.
    Ruggeri, M.
    Biasi, D.
    Adami, S.
    Schiavon, F.
    Punzi, L.
    Cicchetti, A.
    De Vita, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 563 - 563
  • [39] Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
    F. Navarro
    J. M. Martinez-Sesmero
    A. Balsa
    C. Peral
    M. Montoro
    M. Valderrama
    S. Gómez
    F. de Andrés-Nogales
    M. A. Casado
    Itziar Oyagüez
    Clinical Rheumatology, 2020, 39 : 2919 - 2930
  • [40] Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
    Navarro, F.
    Martinez-Sesmero, J. M.
    Balsa, A.
    Peral, C.
    Montoro, M.
    Valderrama, M.
    Gomez, S.
    De Andres-Nogales, F.
    Casado, M. A.
    Oyaguez, Itziar
    CLINICAL RHEUMATOLOGY, 2020, 39 (10) : 2919 - 2930
12345